Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01185 (
vasopressin
)
23,126
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The neuropil located ventral to the SON was investigated by the use of immunoperoxidase staining for neurophysins, oxytocin and
vasopressin
, and electron microscopy. The study was performed in six groups of rats: 1) control; 2) infusion of isotonic saline into the
CSF
; 3) infusion of hypertonic saline into the
CSF
; 4) drinking hypertonic saline for 4 days; 5) same as group 4 but injection of colchicine into the
CSF
on second day of dehydration; 6) salt loading for 3 months. In the control rats the ventral neuropil contained a few immunoreactive processes, the general morphology of which was completely different from that of the neurosecretory axons emerging from the SON at its dorsal aspect. In rats of groups 3 to 6 the ventral processes (VP) became loaded with neurosecretory granules, whereas the perikarya and axons were depleted. Based on their general morphology and reactivity pattern it is suggested that the VP are dendrites. Most of these "dendrites" were embedded in a glial cushion formed by the processes of a particular type of marginal glia. Some of these "dendrites" enveloped an arteriole penetrating the optic tract. All VP were rich in synaptic contacts. The possibility that the VP of neurosecretory cells may be functionally related to the subarachnoid
CSF
and the arteriolar blood flow is discussed.
...
PMID:Immunocytochemistry and ultrastructure of the neuropil located ventral to the rat supraoptic nucleus. 671 4
Here we have reviewed mainly the cerebral regulation of water intake and its relationship with the regulation of the water-retaining
antidiuretic hormone
(
ADH
). Much new information of obvious interest has been gained by experiments in conscious animals, by studies in healthy humans, and by clinical investigations. Of particularly great value has been the development of a sensitive radioimmunoassay for determination of plasma
ADH
(59). The sketchy picture that emerges in light of this new information is as follows. The osmotic regulation of water intake and
ADH
secretion is exerted by juxtacerebroventricular sensors apparently mainly located on the anterior border of the third ventricle. These sensors may be accessible both to
CSF
-borne and blood-borne stimuli and inhibitors, and their activity seems to be correlated to the Na concentration of the ECF rather than to its tonicity. A less sensitive volume regulation of water intake and
ADH
secretion is effectuated by cardiovascular distention and pressure receptors monitoring the effective circulating blood volume, and in severe volume depletion states also by the renin-angiotensin system (RAS). Afferent impulses from the cardiovascular receptors exert a tonic inhibition of the
ADH
release by acting upon its final neuronal link (the cells of the supraoptic and paraventricular nuclei). Afferent inflow from these receptors also inhibits thirst to some extent, perhaps by preventing at some synaptic level information from cerebral "thirst" sensors from reaching other parts of the brain where the information is converted into a conscious urge to drink. Therefore, increased cardiovascular receptor activity becomes manifested as elevated osmotic thresholds for
ADH
liberation and thirst. Severe volume depletion may induce RAS hyperactivity to such an extent that generated angiotensin II stimulates the
ADH
release and water intake. Demonstrated cerebral Na/angiotensin interaction suggests that this may occur via an angiotensin-induced lowering of the stimulus threshold for the sensors involved in the osmotic control of water balance. Cerebral damage affecting the sensors responsible for the osmotic regulation of water intake and
ADH
release may result in hypo- or adipsia associated with latent diabetes insipidus, and is apparently the ultimate cause of "essential" hypernatremia. This fragmentary outline of the cerebral control of water intake is based to a considerable extent upon circumstantial evidence, and is for that reason speculative on many points.
...
PMID:Regulation of water intake. 676 37
Twenty-six patients had cryptococcal meningitis and 16 patients had tuberculous meningitis. Underlying conditions were mostly immunosuppressive diseases in patients with cryptococcosis and chronic debilitating diseases in patients with tuberculosis. There were few distinguishing charact eristics between the two infections with regard to symptoms and signs. The presence of a miliary pattern on chest roentgenogram and inappropriate secretion of
antidiuretic hormone
were nonspecific but helpful signs supporting a diagnosis of tuberculous meningitis; the presence of cryptococcal antigen was both a specific and sensitive indicator of cryptococcal meningitis. Acid-fast smears of
CSF
and the tuberculin skin test were of little help diagnostically, being positive in only 18% and 31%, respectively, of patients with tuberculous meningitis. Substantial delays in diagnosis and treatment were associated with increased mortality.
...
PMID:Comparison of cryptococcal and tuberculous meningitis. 682 55
We have studied plasma and cerebrospinal fluid
vasopressin
(
CSF
-AVP) and osmolality in 28 patients with cervical or lumbar pain syndromes (control patients), 11 patients with normal pressure hydrocephalus (NPH) and in 5 patients with benign intracranial hypertension (BIH). Vasopressin concentration in lumbar
CSF
to a high extent reflected the actual ventricular
CSF
-AVP concentration. In all groups
CSF
-AVP was lower than plasma AVP. Mean
CSF
-AVP in the control group was 1.3 pg/ml +/- 0.1 (SEM). In the NPH patients, who all suffered from severe dementia,
CSF
-AVP level was not different from that found in the control group (1.4 pg/ml +/- 0.2). In contrast to the findings in the two other groups
CSF
osmolality in BIH patients was higher than plasma osmolality (P less than 0.0).
CSF
-AVP in the BIH patients, characterized by an elevated intracranial pressure (ICP), was higher than in the control group (2.7 pg/ml +/- 0.4, P less than 0.001).
...
PMID:Vasopressin in the cerebrospinal fluid of patients with normal pressure hydrocephalus and benign intracranial hypertension. 711 92
The antidiuretic effect of the simultaneous intracerebroventricular (ICV) infusion of 0.24 M NaCl (0.02 ml/min) and intravenous (i.v.) infusion of angiotensin II (12 ng/kg X min) was studied in hydrated goats, and was compared to the antidiuretic effects of the separate infusions. The combined infusions inhibited the water diuresis for 30 min, whereas the separate infusions only reduced the water diuresis by 25% (ICV NaCl) and by 50% (i.v. angiotensin). The combined infusions increased the urine osmolality on the average by 415%. Corresponding increases induced by ICV NaCl and by i.v. angiotensin were 100 and 160%. The results suggest that systemic angiotensin II and elevated
CSF
NaCl concentration interact and potentiate each other as stimuli for
antidiuretic hormone
secretion. It is postulated that this synergism may help to preserve body water in hypovolemic conditions associated with hyperactivity of the renal renin-angiotensin system.
...
PMID:Potentiation of antidiuretic response to systemic angiotensin II by elevation of CSF NaCl concentration. 716 57
Methionine-enkephalin-like substance was measured in
CSF
by the radioreceptor-assay established by Furui et al. Samples were obtained from preoperative 20 cases, in which were included 11 cases of pituitary adenoma, 3 cases of craniopharyngioma, 2 cases of pseudtumor cerebri and 4 normal cases, by lumbar puncture. Also postoperative measurement of this substance and pre- and postoperative measurement of ACTH in plasma were performed in 5 cases of Cushing's disease. Five ml of
CSF
was chromatograpied on two successive columns, lyophilized and assayed for opiate receptor affinity against 3H-dihydromorphine. Measured values were expressed as methionine-enkaphalin equivalents using the displacement curve run in parellel. Methionine-enkephalin-like substance level ranged from less than 0.5 to 20.0 pmoles/ml in all cases and mean value was 2.6 pmoles/ml (+/- 1.0 S.E.) in normal subjects. In Cushing's disease the level was not elevated preoperatively (2.1 +/- 0.3) and did not significantly decrease postoperatively (1.6 +/- 0.4 pmoles/ml) in contrast to the decrease of ACTH in plasma. It is suggested that methionine-enkephalin-like substance in
CSF
is not derived from ACTH producing cells of pituitary gland. One case of craniopharyngioma showed very high value. This case revealed diabetes insipidus at sampling. The possibility of participation of methionine-enkephalin in secretion of
antidiuretic hormone
was discussed.
...
PMID:[Measurement of methionine-enkephalin-like substance in CSF from normal subjects and patients with pituitary adenoma (author's transl)]. 737 Jan 37
Constant intraventricular infusion (3.3--6.6 microliters/min) of artificial cerebrospinal fluid with sodium concentrations of 100, 150, 200, 250, 300, and 350 mM produced a linear dose-related change in renal sodium excretion in conscious, unrestrained Sprague-Dawley rats. The periventricular receptors stimulated were able to evoke substantial changes in body sodium balance; the 350 mM Na
CSF
produced an estimated 14% deficit in the content of Na in the extracellular fluid over a 5-hour infusion period. This is the first demonstration of such a dose-response relation over a wide range of
CSF
Na concentration (above and below normal) in conscious animals. Both the dose-response relation, and the magnitude of the effects, suggests an important physiologic role for this control mechanism. The natriuresis in response to 300 mM sodium infusion was identical in Long-Evans Brattleboro rats heterozygous for diabetes insipidus (DI), and in Sprague-Dawley rats, but was completely absent in homozygous animals. Although the experimental methods (conscious unrestrained rats) precluded simultaneous evaluation of efferent pathways other than
antidiuretic hormone
(
ADH
), the evidence from the DI rats suggests that
ADH
may be the efferent pathway for the response.
...
PMID:Dose-response relation of CSF sodium and renal sodium excretion, and its absence in homozygous Brattleboro rats. 737 18
Water deprivation, drinking water containing 2% NaCl, or systemic injection with histamine or nicotine markedly increased plasma levels of
vasopressin
in rats. In contrast, none of the applied stimuli changed
vasopressin
levels in the
CSF
collected simultaneously from the same animal. These data suggest that the blood levels of
vasopressin
are controlled quite differently from
CSF
levels of this hormone.
...
PMID:Differential effects of various stimuli on AVP levels in blood and cerebrospinal fluid. 744 37
I describe how the dietary intake of strong ions potentially affects the regulation of ventilation and the PCO2 of body fluids in two ways. First, changing the dietary intake of NaCl can alter the concentration difference between strong cations and strong anions (the [SID] of Stewart) of body fluids. Experimental observations indicate that the [SID] in brain fluids or cerebrospinal fluid ([SID]
CSF
) could be the stimulus to central chemoreceptors. [SID]
CSF
consistently predicts ventilatory regulation of PCO2, whereas [H+]
CSF
does not. PCO2 acts as a stimulus to ventilation independently of [SID]
CSF
and possibly at higher as well as lower centers of the nervous system. I relate the concept of [SID] regulation of arterial PCO2 to the alphastat hypothesis of protein function, respiratory control, and [H+] homeostasis. Second, altering the dietary intake of NaCl changes the levels of hormones involved in salt and water balance. Angiotensin II acts centrally to stimulate ventilation. Evidence for the roles of both the renal and brain renin-angiotensin systems in respiratory control, and the modulation of respiratory control by
vasopressin
are reviewed. These peptide systems probably act via circumventricular organs of the brain to affect respiratory control and (or) by changing strong ion concentrations in brain fluids. Questions to be resolved on the role of [SID]
CSF
and hormones in respiratory adaptations, and experiments required to improve our understanding of the control of ventilation, are addressed in the concluding comments.
...
PMID:The physicochemistry of [H+] and respiratory control: roles of PCO2, strong ions, and their hormonal regulators. 773 41
The objective of the present study was to examine the role of
vasopressin
in the regulation of LH secretion in the rhesus monkey. The effect of
vasopressin
administration on basal LH secretion and
vasopressin
antagonism on stress-induced inhibition of LH secretion were examined. Intracerebroventricular (i.c.v.) infusion of
vasopressin
(20 micrograms/h) to chair restrained ovariectomized rhesus monkeys (n = 5) decreased the area under the LH curve by -51.61 +/- 13.73 ng/ml/h compared to -8.35 +/- 7.11 ng/ml/h following infusion of artificial
CSF
(aCSF; p = 0.021). This effect was independent of any change in mean arterial pressure. Subsequently, the role of
vasopressin
in hypoglycemia-induced suppression of LH was examined. Administration of insulin (1 U/kg BW) to chair-restrained ovariectomized rhesus monkeys decreased the area under the LH curve by -60.88 +/- 19.77 ng/ml/h. The decrease in LH was significantly different from that observed in aCSF-infused euglycemic controls which exhibited a slight decrease in LH (-8.35 +/- 7.11 ng/ml/h; p = 0.036). In contrast, the area under the LH curve was increased slightly (1.42 +/- 11.93 ng/ml/h) when insulin administration was combined with i.c.v. infusion of the
vasopressin
antagonist [deaminopenicillamine1, O-methyl-tyrosine2, arginine8]-
vasopressin
(120 micrograms/h; p = 0.013 vs. insulin only). The demonstration that
vasopressin
administration inhibits LH secretion whereas
vasopressin
antagonism prevents hypoglycemia-induced LH suppression suggests that
vasopressin
is a physiological inhibitor of LH secretion in the rhesus monkey.
...
PMID:Vasopressin mediates hypoglycemia-induced inhibition of luteinizing hormone secretion in the ovariectomized rhesus monkey. 796 88
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>